In vitro activity of linezolid against staphylococci
- 1 June 2000
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 6 (6), 331-333
- https://doi.org/10.1046/j.1469-0691.2000.006006331.x
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Antibiotic resistance in Gram-positive bacteria: epidemiological aspectsJournal of Antimicrobial Chemotherapy, 1999
- In Vitro Activities of Linezolid against Important Gram-Positive Bacterial Pathogens Including Vancomycin-Resistant EnterococciAntimicrobial Agents and Chemotherapy, 1999
- Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus isolates in the Dusseldorf areaJournal of Antimicrobial Chemotherapy, 1999
- The in-vitro activity of linezolid (U-100766) and tentative breakpointsJournal of Antimicrobial Chemotherapy, 1998
- Multidrug Resistance — A Sign of the TimesNew England Journal of Medicine, 1998
- The Pharmacologic and Bacteriologic Properties of Oxazolidinones, a New Class of Synthetic AntimicrobialsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1998
- The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycinAntimicrobial Agents and Chemotherapy, 1997
- Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactionsAntimicrobial Agents and Chemotherapy, 1997
- Increasing incidence and widespread dissemination of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals in central Europe, with special reference to German hospitalsClinical Microbiology & Infection, 1997
- Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibilityJournal of Antimicrobial Chemotherapy, 1997